FPTW
AMGN icon

Franklin, Parlapiano, Turner & Welch’s Amgen AMGN Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-40
Closed -$7K – 52
2017
Q1 		$7K Buy
40
+5
+14% +$831 ﹤0.01% 108
2016
Q4 		$5K Hold
35
– – ﹤0.01% 111
2016
Q3 		$6K Hold
35
– – ﹤0.01% 109
2016
Q2 		$5K Buy
35
+15
+75% +$2.33K ﹤0.01% 101
2016
Q1 		$3K Buy
20
+5
+33% +$743 ﹤0.01% 108
2015
Q4 		$2K Hold
15
– – ﹤0.01% 114
2015
Q3 		$2K Buy
+15
New +$2.36K ﹤0.01% 96

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's AMGN Position: Q2 2017 in Review

Franklin, Parlapiano, Turner & Welch sold out of Amgen (AMGN) in Q2 2017, closing a stake of 40 shares — an estimated $7K sold.

Franklin, Parlapiano, Turner & Welch first reported a position in AMGN in Q3 2015 and held it in 7 quarters. The position peaked at $7K in Q1 2017. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Franklin, Parlapiano, Turner & Welch reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Franklin, Parlapiano, Turner & Welch sold 40 Amgen shares in Q2 2017, an estimated $7K.
  • Franklin, Parlapiano, Turner & Welch first reported a position in Amgen in Q3 2015 and held it in 7 quarters.
  • Franklin, Parlapiano, Turner & Welch's Amgen position peaked at $7K in Q1 2017.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2017, filed 17 Jul 2017.